Steven Cohen’s Tonix Pharmaceuticals TNXP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$14.9M Buy
1,166,752
+1,041,338
+830% +$13.4M 0.02% 1044
2026
Q1
$1.72M Sell
125,414
-494,619
-80% -$7.61M ﹤0.01% 2419
2025
Q4
$9.68M Buy
+620,033
New +$11.4M 0.01% 1376
2025
Q1
Sell
-15,963
Closed -$526K 2538
2024
Q4
$526K Buy
+15,963
New +$332K ﹤0.01% 1653

Other funds holding TNXP

Steven Cohen's TNXP Position: Q2 2026 in Review

Steven Cohen increased its Tonix Pharmaceuticals (TNXP) stake by 830% in Q2 2026, buying an estimated $13.4M and bringing the position to 1,166,752 shares worth $14.9M. The position accounts for 0.02% of the portfolio, ranked #1044.

Steven Cohen first reported a position in TNXP in Q4 2024 and has held it in 4 quarters since. 102 funds tracked by Wall St. Rank hold TNXP as of Q2 2026.

  • Steven Cohen held 1,166,752 shares of Tonix Pharmaceuticals worth $14.9M as of Q2 2026.
  • Steven Cohen bought 1,041,338 Tonix Pharmaceuticals shares in Q2 2026, an estimated $13.4M.
  • Tonix Pharmaceuticals made up 0.02% of Steven Cohen's portfolio in Q2 2026, its #1044 holding.
  • Steven Cohen first reported a position in Tonix Pharmaceuticals in Q4 2024 and has held it in 4 quarters since.
  • 102 funds tracked by Wall St. Rank held Tonix Pharmaceuticals as of Q2 2026.

Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.